NM_024675.4(PALB2):c.2174C>T (p.Ser725Leu) AND Hereditary cancer-predisposing syndrome
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- Dec 4, 2023
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000774293.3
Allele description [Variation Report for NM_024675.4(PALB2):c.2174C>T (p.Ser725Leu)]
NM_024675.4(PALB2):c.2174C>T (p.Ser725Leu)
Condition(s)
- Name:
- Hereditary cancer-predisposing syndrome
- Synonyms:
- Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672
-
Homo sapiens ADAM metallopeptidase with thrombospondin type 1 motif 9 (ADAMTS9),...
Homo sapiens ADAM metallopeptidase with thrombospondin type 1 motif 9 (ADAMTS9), transcript variant 4, mRNAgi|1675158146|ref|NM_001318781.2|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Feb 20, 2024